Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arnebia euchroma versus clotrimazole for vulvovaginal candidiasis
IRCT20180407039211N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clotrimazole in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Itching, Erythema and 6 more. Started Sep 2018; status: completed.
02
Drugs
clotrimazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on IRCT20180407039211N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180407039211N1.